Recombinant human TSH stimulated thyroglobulin levels at remnant ablation predict structural incomplete response to treatment in patients with differentiated thyroid cancer

In patients with differentiated thyroid cancer, stimulated thyroglobulin (sTg) levels after thyroid hormone withdrawal (THW) at remnant ablation (RA) and at 6 to 12 months are known to have good prognostic value. This study aimed to evaluate the prognostic impacts and best cutoff values of sTg level...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Ha, Jeonghoon, Kim, Min Hee, Jo, Kwanhoon, Lim, Yejee, Bae, Ja Seong, Lee, Sohee, Kang, Moo Il, Cha, Bong Yun, Lim, Dong Jun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2017
Gaiak:
4300
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5521902/
https://ncbi.nlm.nih.gov/pubmed/28723762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000007512
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak